EUVIMEDEUVIMED entdecken
Crossref

Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy

Zaixiang Fang, Ling Lin, Zhiqian Li, Lei Gu, Dayi Pan, Yunkun Li, Jie Chen, Haitao Ding, Xiaohe Tian, Qiyong Gong, Kui Luo

Acta Biomaterialia · 2023-07 · 164 · 422-434

DOI: 10.1016/j.actbio.2023.04.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-07. Verfasst von Zaixiang Fang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Huaxi MR Research Center (HMRRC), Clinical Research Center for Breast, Department of Breast Surgery, Frontiers Science Cente…. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan University, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of chemotherapy and photodynamic therapy (PDT) has the potential to complement single-drug therapies, but chemotherapeutic agents and photosensitizers often have compromised therapeutic efficacies and strong toxic effects. In this study, we exploited nanotechnology to address this challenge by utilizing heparin as a carrier for co-delivery of chemotherapeutic drugs and photosensitizers for synergistic cancer therapy. Specifically, heparin-paclitaxel (HP-PTX) and heparin-pyropheophorbide-a (HP-Ppa) were synthesized by attaching paclitaxel (PTX), a small molecular chemotherapeutic drug, through a reactive oxygen species (ROS)-responsive linker and Ppa, a photosensitizer, to heparin, respectively. Two conjugates were co-assembled into a nanomedicine, HP-PP nanoparticles (NPs), for controllable co-delivery of Ppa and PTX into tumor cells. HP-PP NPs significantly enhanced the in vitro stability of HP-Ppa and the photostability of Ppa, and the synergistic actions of chemotherapy and PDT were confirmed by both in vitro and in vivo antitumor studies. Notably, HP-PP NPs enhanced tumor accumulation of Ppa up to 11-fold and the treatment of 4T1 tumor-bearing mice with HP-PP NPs resulted in a tumor growth inhibition of 98.1% without systemic toxicity. The strategy of co-assembly of heparin conjugates may offer great potential in enhancing the efficacy of combination therapy. STATEMENT OF SIGNIFICANCE: We proposed a nano-delivery system, HP-PP NPs, which was constructed by co-assembly of heparin-paclitaxel (HP-PTX) and heparin-pyropheophorbide-a (HP-Ppa), to co-deliver PTX and Ppa for synergistic cancer therapy. HP-PP NPs enhanced the photostability and the in vitro stability of Ppa and HP-Ppa, and induced greater cytotoxicity than HP-PTX NPs or HP-Ppa NPs. This co-delivery system displays enhanced tumor accumulation and has a remarkable synergistic antitumor effect with a tumor growth inhibition of 98.1%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNeoplasmsAnimalsMicePharmaceutical PreparationsPhotosensitizing AgentsDrug Delivery SystemsNanomedicineHeparinCell Line, TumorPaclitaxelMice, Inbred BALB C

Stichwörter der Autor:innen

Cancer combination therapyCo-assemblyCo-deliveryHeparin conjugatesStimuli-responsibility

Substanzen

Pharmaceutical PreparationsPhotosensitizing AgentsHeparinPaclitaxel

Autor:innen und Institutionen

  • Department of Radiology, Huaxi MR Research Center (HMRRC), Clinical Research Center for Breast, Department of Breast Surgery, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Bioth…

Förderung

  • National Natural Science Foundation of China
  • Sichuan University
  • West China Hospital, Sichuan University

Zitieren

APA

Fang, Z., Lin, L., Li, Z., Gu, L., Pan, D., Li, Y., Chen, J., Ding, H., Tian, X., Gong, Q., & Luo, K. (2023). Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy. Acta Biomaterialia, 164, 422-434. https://doi.org/10.1016/j.actbio.2023.04.016

Vancouver

Fang Z, Lin L, Li Z, Gu L, Pan D, Li Y, et al. Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy. Acta Biomaterialia. 2023;164:422-434. doi:10.1016/j.actbio.2023.04.016

BibTeX
@article{Fang2023,
  author = {Fang, Zaixiang and Lin, Ling and Li, Zhiqian and Gu, Lei and Pan, Dayi and Li, Yunkun and Chen, Jie and Ding, Haitao and Tian, Xiaohe and Gong, Qiyong and Luo, Kui},
  title = {Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy},
  journal = {Acta Biomaterialia},
  year = {2023},
  volume = {164},
  pages = {422--434},
  doi = {10.1016/j.actbio.2023.04.016}
}
Kostenlos starten →